Article Versions Notes

Ge W, Yue M, Wang Y, Wang Y, Xue S, Shentu D, Mao T, Zhang X, Xu H, Li S, et al. A Novel Molecular Signature of Cancer-Associated Fibroblasts Predicts Prognosis and Immunotherapy Response in Pancreatic Cancer. International Journal of Molecular Sciences. 2023; 24(1):156. https://doi.org/10.3390/ijms24010156

Ge, Weiyu, Ming Yue, Yanling Wang, Yongchao Wang, Shengbai Xue, Daiyuan Shentu, Tiebo Mao, Xiaofei Zhang, Haiyan Xu, Shumin Li, and et al. 2023. "A Novel Molecular Signature of Cancer-Associated Fibroblasts Predicts Prognosis and Immunotherapy Response in Pancreatic Cancer" International Journal of Molecular Sciences 24, no. 1: 156. https://doi.org/10.3390/ijms24010156

Ge, W., Yue, M., Wang, Y., Wang, Y., Xue, S., Shentu, D., Mao, T., Zhang, X., Xu, H., Li, S., Ma, J., Wang, L., & Cui, J. (2023). A Novel Molecular Signature of Cancer-Associated Fibroblasts Predicts Prognosis and Immunotherapy Response in Pancreatic Cancer. International Journal of Molecular Sciences, 24(1), 156. https://doi.org/10.3390/ijms24010156